Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 16,627 | 12,874 | 9,111 | 6,957 | 28,935 |
| Gross Profit | 16,627 | 12,874 | 9,111 | 6,957 | 28,935 |
| Operating Expenses | 137,434 | 149,321 | 153,881 | 146,000 | 142,938 |
| Operating Income | -120,807 | -136,447 | -144,770 | -139,043 | -114,003 |
| Other Income | 6,478 | 7,549 | 9,058 | -7,932 | 6,567 |
| Pre-tax Income | -114,329 | -128,898 | -135,712 | -146,975 | -107,436 |
| Net Income Continuous | -114,329 | -128,898 | -135,712 | -146,975 | -107,436 |
| Net Income | $-114,329 | $-128,898 | $-135,712 | $-146,975 | $-107,436 |
| EPS Basic Total Ops | -1.10 | -1.27 | -1.34 | -1.52 | -1.12 |
| EPS Basic Continuous Ops | -1.10 | -1.27 | -1.34 | -1.52 | -1.13 |
| EPS Diluted Total Ops | -1.10 | -1.27 | -1.34 | -1.52 | -1.12 |
| EPS Diluted Continuous Ops | -1.10 | -1.27 | -1.34 | -1.52 | -1.13 |
| EPS Diluted Before Non-Recurring Items | -1.10 | -1.24 | -1.34 | -1.31 | N/A |
| EBITDA(a) | $-118,309 | $-133,881 | $-142,162 | $-136,444 | $-111,491 |